A Random Walk Rule for Phase I Clinical Trials
From MaRDI portal
Publication:4349992
DOI10.2307/2533975zbMath0877.62075OpenAlexW2152155324WikidataQ73436225 ScholiaQ73436225MaRDI QIDQ4349992
Nancy Flournoy, William F. Rosenberger, Stephen D. Durham
Publication date: 27 August 1997
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://semanticscholar.org/paper/724fae826be4426069dbe377ed74456475e8db3d
adaptive designsquantile estimationup-and-down designstoxicity studiessmall sample distribution theory
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05)
Related Items (26)
Designs for Single- or Multiple-Agent Phase I Trials ⋮ An application of reinforced urn processes to determining maximum tolerated dose ⋮ Sequential design for binary dose-response experiments ⋮ A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents ⋮ A new design of the continual reassessment method ⋮ Information in a two-stage adaptive optimal design ⋮ Stochastic approximation and modern model-based designs for dose-finding clinical trials ⋮ A new look at evaluating MTD designs in cancer research ⋮ Adaptive clinical trial designs for phase I cancer studies ⋮ Continual reassessment method with multiple toxicity constraints ⋮ On the consistency of the continual reassessment method with multiple toxicity constraints ⋮ Simple benchmark for complex dose finding studies ⋮ Up-and-down experiments of first and second order ⋮ Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities ⋮ Group up-and-down designs for dose-finding ⋮ Statistical Properties of a Modified Accelerated Design for Phase I Cancer Clinical Trials ⋮ Dose Finding Using the Biased Coin Up-and-Down Design and Isotonic Regression ⋮ Bayesian Optimal Designs for Phase I Clinical Trials ⋮ On optimal designs for clinical trials: an updated review ⋮ Derivation of Exact Distributions Following an Up-and-Down Design ⋮ Individualized dosing for multiple ordered groups of patients ⋮ Operating characteristics of the standard phase I clinical trial design. ⋮ Randomized group up and down experiments ⋮ Properties of frequency distributions induced by general up-and-down methods for estimating quantiles ⋮ A sequential design for maximizing the probability of a favourable response ⋮ A conversation with Nancy Flournoy
This page was built for publication: A Random Walk Rule for Phase I Clinical Trials
